New data indicates that retatrutide, a dual-action medication, may represent a major improvement in weight reduction . This drug combines the effects of a GLP-1 receptor and a GIP receptor , seemingly https://bookmarkforce.com/story21734675/a-new-breakthrough-for-weight-management